Obstetrics & Gynecology · Birmingham, AL
NPI
1912960527
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2006 Brookwood Medical Ctr Dr Ste 310
Birmingham, AL, 35209
Phone (205) 877-2121
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,036
151 services
Medicare patients, 2024
117
Average age 71
Drug cost, 2024
$67K
777 prescriptions
Company payments, 2025
$648
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles G Banks was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 64 times for 64 patients. In total Charles G Banks billed 151 services in 14 codes, and Medicare paid $9,036.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-15.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 64 | 64 | $34.62 | $2,216 |
| 99213 Office E&M - Established | Office | 48 | 45 | $56.11 | $2,693 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 12 | 12 | $39.09 | $469 |
By year: 2022 $6,321 for 115 services; 2023 $6,969 for 119 services; 2024 $9,036 for 151 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles G Banks prescribed most often to Medicare patients was Estradiol, with 196 prescriptions and refills. In total Charles G Banks wrote 777 Medicare prescriptions that cost $67K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 196 | 546 | 58 | $7,381 |
| Estradiol-Norethindrone Acetat Estradiol/Norethindrone Acet | 56 | 102 | Under 11 | $5,404 |
| Fluconazole Generic | 50 | 52 | 35 | $442 |
| Valacyclovir Valacyclovir Hcl | 48 | 74 | 12 | $1,995 |
| Progesterone Progesterone, Micronized | 40 | 97 | 13 | $2,881 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 39 | 39 | 24 | $723 |
| Premarin Estrogens, Conjugated | 31 | 70 | Under 11 | $14K |
| Dotti Estradiol | 31 | 47 | Under 11 | $2,952 |
| Estradiol (Twice Weekly) Estradiol | 26 | 62 | Under 11 | $2,878 |
| Levothyroxine Sodium Generic | 18 | 54 | Under 11 | $201 |
| Myrbetriq Mirabegron | 17 | 23 | Under 11 | $10K |
| Halobetasol Propionate Generic | 16 | 16 | Under 11 | $398 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 11 | 32 | Under 11 | $344 |
Brand drugs: - claims; generic drugs: 666 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles G Banks $648 ($648 in general payments such as food, travel and fees) from 12 companies. The largest payer was Millicent US Inc with $192.
| Company | Payments | Amount |
|---|---|---|
| Millicent US Inc | 10 | $192 |
| Astellas Pharma US Inc 4503.T | 9 | $176 |
| Mayne Pharma Commercial LLC | 7 | $70.63 |
| Ethicon US, LLC JNJ | 2 | $66.6 |
| Sage Therapeutics, LLC SAGE | 2 | $38.87 |
| Exeltis, USA Inc. | 1 | $17.53 |
| Meditrina | 1 | $17.28 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $16.19 |
| Shield Therapeutics Inc STX.L | 1 | $14.71 |
| Minerva Surgical, Inc UTRS | 1 | $14.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.